We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2B
AUM Growth
+$231M
Cap. Flow
+$286M
Cap. Flow %
14.32%
Top 10 Hldgs %
8.34%
Holding
1,933
New
619
Increased
448
Reduced
311
Closed
543

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$17.8M
2
INTC icon
Intel
INTC
+$17.4M
3
EOG icon
EOG Resources
EOG
+$12.8M
4
AMZN icon
Amazon
AMZN
+$11.9M
5
NVDA icon
NVIDIA
NVDA
+$10.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$25M
2
HLF icon
Herbalife
HLF
+$20.8M
3
HD icon
Home Depot
HD
+$12.7M
4
BKNG icon
Booking.com
BKNG
+$12M
5
CMG icon
Chipotle Mexican Grill
CMG
+$11.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.88%
2 Technology 15.21%
3 Financials 12.06%
4 Industrials 12.01%
5 Healthcare 11.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VATE icon
1351
INNOVATE Corp
VATE
$106M
$30K ﹤0.01%
1,297
-1,719
-57% -$37.3K
DMK
1352
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$30K ﹤0.01%
616
-266
-30% -$19.1K
CORV
1353
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$30K ﹤0.01%
+14,803
New +$30K
FLNA
1354
Filana Therapeutics
FLNA
$42M
$29K ﹤0.01%
+24,043
New +$30.9K
CRDF icon
1355
Cardiff Oncology
CRDF
$63M
$28K ﹤0.01%
18,378
+1,781
+11% +$3.47K
FTK icon
1356
Flotek Industries
FTK
$789M
$28K ﹤0.01%
+2,124
New +$32.3K
ZSAN
1357
DELISTED
Zosano Pharma Corporation
ZSAN
$27K ﹤0.01%
+489
New +$43.8K
SRAX
1358
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$26K ﹤0.01%
+11,298
New +$40.9K
BIOC
1359
DELISTED
Biocept, Inc.
BIOC
$24K ﹤0.01%
+100
New +$28.8K
KOPN icon
1360
Kopin
KOPN
$586M
$23K ﹤0.01%
+34,352
New +$34.3K
CYPH
1361
Cypherpunk Technologies Inc
CYPH
$64M
$23K ﹤0.01%
1,968
+422
+27% +$7.27K
TRX icon
1362
TRX Gold Corp
TRX
$249M
$23K ﹤0.01%
+29,069
New +$26.5K
ISEE
1363
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$23K ﹤0.01%
20,177
-3,700
-15% -$4.3K
NCSM icon
1364
NCS Multistage Holdings
NCSM
$116M
$22K ﹤0.01%
+548
New +$27.9K
NTGN
1365
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$22K ﹤0.01%
+12,922
New +$39.3K
FBRX icon
1366
Forte Biosciences
FBRX
$1.57B
$21K ﹤0.01%
85
+40
+89% +$60.7K
ZVO
1367
DELISTED
Zovio Inc. Common Stock
ZVO
$21K ﹤0.01%
+10,523
New +$31.7K
PALI icon
1368
Palisade Bio
PALI
$341M
$19K ﹤0.01%
+2
New +$27.9K
PSHG icon
1369
Performance Shipping
PSHG
$23.5M
$19K ﹤0.01%
+136
New +$19K
IBRX icon
1370
ImmunityBio
IBRX
$7.15B
$18K ﹤0.01%
+14,578
New +$18.1K
SALM
1371
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$18K ﹤0.01%
+11,879
New +$22.3K
ALO
1372
DELISTED
Alio Gold Inc
ALO
$18K ﹤0.01%
+28,745
New +$21.9K
KG
1373
Kestrel Group
KG
$66.1M
$17K ﹤0.01%
1,156
-3,180
-73% -$37.4K
SDEV
1374
Stablecoin Development Corp
SDEV
$30.6M
$17K ﹤0.01%
+5
New +$28.6K
DNR
1375
DELISTED
Denbury Resources, Inc.
DNR
$17K ﹤0.01%
+14,105
New +$16.3K
53 54
55
56 57

Similar funds

MA
MANA Advisors New York $3.06M AUM 7.13% 1-Year Est. Return
FFIM
Founders Fund III Management San Francisco, California $435K AUM
LC
Lunia Capital Dallas, Texas $4.49M AUM 42.82% 1-Year Est. Return
YEPV
Yorktown Energy Partners VI New York $6.21M AUM 74.4% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM

A.R.T. Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, A.R.T. Advisors held 1,933 positions worth $2B, up 13% from $1.77B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

A.R.T. Advisors deployed $286M of net new capital in Q3 2019, opening 619 new positions and adding to 448 existing holdings. Its largest new stake was Netflix: 570,000 shares worth $15.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Booking.com, an estimated $12M trimmed.

  • A.R.T. Advisors's largest Q3 2019 buy was Netflix: 570,000 shares worth $15.3M.
  • A.R.T. Advisors added most to Intel in Q3 2019, an estimated $17.4M increase.
  • A.R.T. Advisors's biggest Q3 2019 reduction was Booking.com, cutting an estimated $12M.
  • A.R.T. Advisors fully exited Apple in Q3 2019, selling an estimated $25M.
  • A.R.T. Advisors's ten largest holdings make up 8.3% of its $2B portfolio in Q3 2019.
  • A.R.T. Advisors opened 619 new positions and closed 543 in Q3 2019.
  • A.R.T. Advisors's portfolio value rose 13% quarter-over-quarter to $2B.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.